U-50488

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameU-50488
Drug Alias NameU-50488
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel alpha subunit blockersPotassium channel blockersKappa opioid receptor agonists
TargetsPotassium channelSodium channel alpha subunitKappa opioid receptor
Therapy Area/IndicationsAnxietyPainArrhythmias, Cardiac +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsAnxietyPainArrhythmias, Cardiac +[5] 

Other Information

ATC CodeN/A
Related LinksWikipedia